Investigational antiviral pritelivir demonstrates efficacy and improved tolerability over current treatments for refractory HSV in high-risk patients.
Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results